Big news for those concerned about their heart health: Pharmaceutical company Merck has created a new pill called enlicitide, which promises to lower "bad" cholesterol as effectively as injectable ...

Currently, individuals with high cholesterol are typically subjected to complex treatment plans, often involving a variety of medications for the remainder of their lives. However, this could soon ...

ATLANTA -- A novel PCSK9 inhibitor safely reduced LDL cholesterol levels with just a single, quick, once-monthly dose, the phase III LIBerate-HR trial showed. Lerodalcibep reduced LDL cholesterol by ...

TARRYTOWN, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (REGN) announced the U.S. Food & Drug Administration (FDA) has extended the approval of Praluent ® (alirocumab) as ...

Lerodalcibep-liga, a once-monthly PCSK9 inhibitor, significantly reduces LDL-C in hypercholesterolemia, including HeFH, with FDA approval for subcutaneous use. The LIBerate Program showed sustained ...

High cholesterol is a common health problem that affects millions of people around the world. When there is too much cholesterol in the blood, it can stick to the walls of arteries and form plaques.

Merck’s new pill, enlicitide, lowered LDL cholesterol by up to 60% in a new trial The pill works just as well as traditional PCSK9 injections but could cost less Researchers hope to receive federal ...

Researchers used tiny DNA-based molecules to cut levels of LDL (bad) cholesterol by nearly 50% in animal models. This was done without the side effects that are often linked to statins.

You can inject Repatha into the abdomen, thigh, or upper arm. It’s injected subcutaneously (under the skin). If you’re injecting it into your upper arm, you may need a family member or caregiver to ...

Scientists report that a new DNA-based treatment lowered bad cholesterol by nearly 50% after one injection targeting the PCSK9 gene.